194 related articles for article (PubMed ID: 20675597)
1. The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
Renner B; Coleman K; Goldberg R; Amura C; Holland-Neidermyer A; Pierce K; Orth HN; Molina H; Ferreira VP; Cortes C; Pangburn MK; Holers VM; Thurman JM
J Immunol; 2010 Sep; 185(5):3086-94. PubMed ID: 20675597
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
Barata L; Miwa T; Sato S; Kim D; Mohammed I; Song WC
J Immunol; 2013 Mar; 190(6):2886-95. PubMed ID: 23390291
[TBL] [Abstract][Full Text] [Related]
3. Membrane protein Crry maintains homeostasis of the complement system.
Wu X; Spitzer D; Mao D; Peng SL; Molina H; Atkinson JP
J Immunol; 2008 Aug; 181(4):2732-40. PubMed ID: 18684964
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
5. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.
Thurman JM; Ljubanović D; Royer PA; Kraus DM; Molina H; Barry NP; Proctor G; Levi M; Holers VM
J Clin Invest; 2006 Feb; 116(2):357-68. PubMed ID: 16444293
[TBL] [Abstract][Full Text] [Related]
6. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
Laskowski J; Renner B; Le Quintrec M; Panzer S; Hannan JP; Ljubanovic D; Ruseva MM; Borza DB; Antonioli AH; Pickering MC; Holers VM; Thurman JM
Kidney Int; 2016 Jul; 90(1):109-22. PubMed ID: 27165610
[TBL] [Abstract][Full Text] [Related]
8. Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion.
Amura CR; Renner B; Lyubchenko T; Faubel S; Simonian PL; Thurman JM
Mol Immunol; 2012 Oct; 52(3-4):249-57. PubMed ID: 22750071
[TBL] [Abstract][Full Text] [Related]
9. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
Atkinson C; He S; Morris K; Qiao F; Casey S; Goddard M; Tomlinson S
J Immunol; 2010 Dec; 185(11):7007-13. PubMed ID: 20962256
[TBL] [Abstract][Full Text] [Related]
10. Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.
Alexander JJ; Lim A; He C; MacDonald RL; Holers VM; Quigg RJ
Immunopharmacology; 1999 May; 42(1-3):245-54. PubMed ID: 10408385
[TBL] [Abstract][Full Text] [Related]
11. An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.
Tchepeleva SN; Thurman JM; Ruff K; Perkins SJ; Morel L; Boackle SA
J Immunol; 2010 Aug; 185(4):2331-9. PubMed ID: 20660348
[TBL] [Abstract][Full Text] [Related]
12. Timing and mechanism of conceptus demise in a complement regulatory membrane protein deficient mouse.
Triebwasser MP; Wu X; Bertram P; Hourcade DE; Nelson DM; Atkinson JP
Am J Reprod Immunol; 2018 Oct; 80(4):e12997. PubMed ID: 29924462
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
Kim DD; Miwa T; Song WC
J Immunol; 2006 Oct; 177(8):5558-66. PubMed ID: 17015743
[TBL] [Abstract][Full Text] [Related]
14. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure.
Schiller B; Cunningham PN; Alexander JJ; Bao L; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jan; 12(1):71-79. PubMed ID: 11134252
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.
Mühlfeld AS; Segerer S; Hudkins K; Farr AG; Bao L; Kraus D; Holers VM; Quigg RJ; Alpers CE
Kidney Int; 2004 Apr; 65(4):1214-23. PubMed ID: 15086460
[TBL] [Abstract][Full Text] [Related]
16. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
[TBL] [Abstract][Full Text] [Related]
17. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
Banda NK; Kraus DM; Muggli M; Bendele A; Holers VM; Arend WP
J Immunol; 2003 Aug; 171(4):2109-15. PubMed ID: 12902517
[TBL] [Abstract][Full Text] [Related]
18. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
19. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
[TBL] [Abstract][Full Text] [Related]
20. Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.
Renner B; Ferreira VP; Cortes C; Goldberg R; Ljubanovic D; Pangburn MK; Pickering MC; Tomlinson S; Holland-Neidermyer A; Strassheim D; Holers VM; Thurman JM
Kidney Int; 2011 Jul; 80(2):165-73. PubMed ID: 21544060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
